Citation Impact
Citing Papers
Subcutaneous Adjusted-Dose Unfractionated Heparin vs Fixed-Dose Low-Molecular-Weight Heparin in the Initial Treatment of Venous Thromboembolism
2004
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
2010 Standout
The epidemiology of venous thromboembolism
2016
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism
2012
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Cerebrovascular disease, beta-amyloid, and cognition in aging
2011
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis
2009
Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study
2012
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Myasthenia Gravis
2016 Standout
Consent for Intravenous Thrombolysis in Acute Stroke
2007
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants
2003
Fibrosing interstitial lung diseases: knowns and unknowns
2019
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review
2004
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Vascular dementia
2015 Standout
Neuroimaging studies of delirium: A systematic review
2008
Venous thromboembolism: disease burden, outcomes and risk factors
2005
Cystic fibrosis
2016 Standout
The controversy of managing calf vein thrombosis
2011
The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors
2012
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
2015 Standout
Delirium in elderly people
2013 Standout
Alzheimer's disease
2011 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
2002
Neuromuscular junction disorders
2016
Unresolved issues in anticoagulant therapy
2003
Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study
2000
Systemic sclerosis
2017 Standout
Chronic ischemic cerebral white matter disease is a risk factor for nonfocal neurologic injury after total aortic arch replacement
2007
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
2008
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
2010
Visceral aneurysms in Ehlers-Danlos syndrome: Case report and review of the literature
2000
Treatment of Deep-Vein Thrombosis
2004
Leisure Activities and the Risk of Dementia in the Elderly
2003 Standout
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects
2016
Sarcoidosis
2013 Standout
Delirium in Acute Subarachnoid Haemorrhage
2004
Cardiac troponin level elevations not related to acute coronary syndromes
2013
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
2019
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Incidental Findings on Brain MRI in the General Population
2007 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors
2011
Platelet Activation and Atherothrombosis
2007 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
2011
2006
The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism
2003
Pulmonary exacerbations in cystic fibrosis
2011
Symptomatic Pulmonary Embolism and the Risk of Recurrent Venous Thromboembolism
2004
How Complex Interactions of Ischemic Brain Infarcts, White Matter Lesions, and Atrophy Relate to Poststroke Dementia
2000
Assessment of Patients' Competence to Consent to Treatment
2007 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis
2005
Alzheimer's disease
2016 Standout
The relative frequency of CFTR mutation classes in European patients with cystic fibrosis
2014
A meta-analysis of anticoagulation for calf deep venous thrombosis
2011
D-Dimer Levels and Risk of Recurrent Venous Thromboembolism
2003
Long-Term Cognitive Impairment after Critical Illness
2013 Standout
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
2013
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
2007
Delirium as a predictor of long-term cognitive impairment in survivors of critical illness
2010
Subarachnoid haemorrhage
2007 Standout
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
2003
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Untangling vascular dementia
2001
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
2007
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Subcortical ischaemic vascular dementia
2002 Standout
Rheumatologic Manifestations of Sarcoidosis
2010
Poststroke dementia
2005
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Clinical Features Associated with a Delayed Diagnosis of Cystic Fibrosis
2000
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Extracellular DNA traps promote thrombosis
2010 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The Case for Managing Calf Vein Thrombi With Duplex Surveillance and Selective Anticoagulation
2010
Immunomodulation in Cystic Fibrosis: Why and How?
2020
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism
2003
Cystic fibrosis: An update for clinicians. Part 2: Hepatobiliary and pancreatic manifestations
2014
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
2005
Natural History of Venous Thromboembolism
2003
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Cytokine Storm
2020 Standout
Delirium in the acute phase after stroke: incidence, risk factors, and outcome.
2011
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
2003
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
2009
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management
2006
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
2008
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Efficacy and Tolerability of Donepezil in Vascular Dementia
2003
Medical Complications After Stroke
2000
Clinical relevance of distal deep vein thrombosis. Review of literature data.
2006
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
2002
Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
2003
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
2014
Epidemiological Studies of the Effect of Stroke on Incident Dementia
2009
Test Accuracy of Cognitive Screening Tests for Diagnosis of Dementia and Multidomain Cognitive Impairment in Stroke
2014
How I treat isolated distal deep vein thrombosis (IDDVT)
2014
Works of I. Durieu being referenced
La sarcoïdose musculaire: à propos d'un cas
1997
Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia
1998
The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome
2014
Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France
2006
Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation
2004
Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study
1999
Adult-Onset Still Disease
2014
Partial splenectomy for portal hypertension in cystic fibrosis related liver disease
2007
Prognostic value of troponins in sepsis: a meta-analysis
2013
Effectiveness of home treatment for patients with cystic fibrosis: The intravenous administration of antibiotics to treat respiratory infections
2008
Idiopathic inflammatory myopathies and the lung
2015
Diagnostic Criteria for Cystic Fibrosis in Men with Congenital Absence of the Vas Deferens
1995
Subepithelial Fibrosis and Degradation of the Bronchial Extracellular Matrix in Cystic Fibrosis
1998
Poststroke dementia
2001
Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients
2016
Confusional State in Stroke
1999
[Vascular and/or cardiac manifestations of type IV Ehlers-Danlos syndrome. 9 cases].
1995
Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
2014
Leukoaraiosis More Than Dementia Is a Predictor of Stroke Recurrence
2003
Influence of prestroke dementia on early and delayed mortality in stroke patients
2003
Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis
2001